Safety and effectiveness of switching to Abacavir/Lamivudine plus rilpivirine for maintenance therapy in virologically suppressed HIV-1 individuals in Singapore (SEALS)
10.1186/s12981-021-00402-7
Saved in:
Main Authors: | Lim, Z. C., Hoo, G. S., Ang, J. H., Teng, C. B., Ang, L. W., Lee, C. C., Leo, Y. S., Law, H. L., Ng, O. T., Wong, C. S. |
---|---|
Other Authors: | PHARMACY |
Format: | Article |
Published: |
BioMed Central Ltd
2022
|
Subjects: | |
Online Access: | https://scholarbank.nus.edu.sg/handle/10635/232699 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
Efficacy and safety of abacavir/lamivudine plus rilpivirine as a first-line regimen in treatment-naïve HIV-1 infected adults
by: Ho, S., et al.
Published: (2021) -
Efficacy and safety of abacavir/lamivudine plus rilpivirine as a first-line regimen in treatment-naïve HIV-1 infected adults
by: Ho, Sharlene, et al.
Published: (2021) -
Safety and effectiveness of switching to abacavir/lamivudine plus rilpivirine for maintenance therapy in virologically suppressed HIV-1 individuals in Singapore (SEALS)
by: Lim, Z. C., et al.
Published: (2021) -
efficacy and safety of fixed-dose combination of stavudine plus lamivudine plus nevirapine in the treatment of HIV infection in adults
by: Thanomsak Anekthananon
Published: (2009) -
Predictors of adherence and virologic outcome in HIV-infected patients treated with abacavir- or indinavir-based triple combination HAART also containing lamivudine/zidovudine
by: Pedro Cahn, et al.
Published: (2018)